Back to Search
Start Over
Long-term safety of subcutaneous immunotherapy with TO-204 in Japanese patients with house dust mite-induced allergic rhinitis and allergic bronchial asthma: Multicenter, open label clinical trial
- Source :
- Allergology International; July 2018, Vol. 67 Issue: 3 p347-356, 10p
- Publication Year :
- 2018
-
Abstract
- To evaluate the long-term safety of subcutaneous immunotherapy with TO-204, a standardized house dust mite (HDM) allergen extracts, we conducted a multicenter, open label clinical trial.
Details
- Language :
- English
- ISSN :
- 13238930 and 14401592
- Volume :
- 67
- Issue :
- 3
- Database :
- Supplemental Index
- Journal :
- Allergology International
- Publication Type :
- Periodical
- Accession number :
- ejs45737940
- Full Text :
- https://doi.org/10.1016/j.alit.2017.11.004